Director at Investors Title (ITIC) granted 750 stock appreciation rights
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Investors Title Co director Tammy Coley received a grant of 750 Stock Appreciation Rights tied to an equal number of common shares. The rights have an exercise price of $238.06 per share, become exercisable on June 30, 2026, and expire on May 20, 2033. This is a compensation-related award, not an open-market stock purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Coley Tammy
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Appreciation Rights | 750 | $0.00 | -- |
Holdings After Transaction:
Stock Appreciation Rights — 0 shares (Direct, null)
Footnotes (1)
Key Figures
Stock Appreciation Rights granted: 750 rights
Underlying common shares: 750 shares
Exercise price: $238.06 per share
+2 more
5 metrics
Stock Appreciation Rights granted
750 rights
Award to director Tammy Coley on May 20, 2026
Underlying common shares
750 shares
Each right corresponds to one common share
Exercise price
$238.06 per share
Exercise price for Stock Appreciation Rights
Exercise date
June 30, 2026
Date rights become exercisable
Expiration date
May 20, 2033
Expiration for Stock Appreciation Rights grant
Key Terms
Stock Appreciation Rights, underlying security, exercise price
3 terms
Stock Appreciation Rights financial
"security_title: "Stock Appreciation Rights" and derivative award description"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
underlying security financial
"underlying_security_title: "Common Stock" and underlying_security_shares"
exercise price financial
"conversion_or_exercise_price: "238.0600" as the exercise price per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider transaction did Investors Title (ITIC) report for Tammy Coley?
Investors Title reported that director Tammy Coley received 750 Stock Appreciation Rights. These derivative awards are tied to 750 common shares at a $238.06 exercise price, reflecting compensation rather than an open-market share purchase or sale.
How many Stock Appreciation Rights did Tammy Coley receive from Investors Title (ITIC)?
Tammy Coley received 750 Stock Appreciation Rights from Investors Title. Each right is linked to one share of common stock, giving derivative-based exposure to 750 shares under the company’s compensation arrangements at a fixed $238.06 exercise price.
What is the exercise price and schedule for Tammy Coley’s Investors Title (ITIC) rights?
The Stock Appreciation Rights granted to Tammy Coley carry a $238.06 exercise price per share. They are scheduled to become exercisable on June 30, 2026, providing future upside participation rather than an immediate stock transaction in the open market.
When do Tammy Coley’s Investors Title (ITIC) Stock Appreciation Rights expire?
Tammy Coley’s 750 Stock Appreciation Rights expire on May 20, 2033. This long-dated expiration gives her several years after the June 30, 2026 exercise date to realize value based on Investors Title’s share performance during that period.
Does the Tammy Coley Form 4 for Investors Title (ITIC) show any stock sales or purchases?
The filing shows a grant of 750 Stock Appreciation Rights, not a common stock sale or open-market purchase. It reflects a compensation-related derivative award, with no reported buy or sell transactions in Investors Title common shares in this record.